Search research articles
Contact Us
Filters
Showing results (21-30 of 23) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 23 results.
Circulation. Heart Failure
|
June 13, 2015
Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial
Athar A Badar, Ana Cristina Perez-Moreno, Nathaniel M Hawkins, et al.
European Heart Journal
|
October 1, 2014
Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Athar A Badar, Ana Cristina Perez-Moreno, Pardeep S Jhund, et al.
European Journal of Heart Failure
|
February 14, 2015
Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme
Athar A Badar, Ana C Perez-Moreno, Nathaniel M Hawkins, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 23) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 23 results.
Circulation. Heart Failure
|
June 13, 2015
Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial
Athar A Badar, Ana Cristina Perez-Moreno, Nathaniel M Hawkins, et al.
European Heart Journal
|
October 1, 2014
Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Athar A Badar, Ana Cristina Perez-Moreno, Pardeep S Jhund, et al.
European Journal of Heart Failure
|
February 14, 2015
Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme
Athar A Badar, Ana C Perez-Moreno, Nathaniel M Hawkins, et al.
Page
of 3